Cardiol Therapeutics Inc. (CRDL)

NASDAQ: CRDL · IEX Real-Time Price · USD

1.980

0.00 (0.00%)

At close: May 3, 2024, 4:00 PM

2.000

+0.020 (1.01%)

After-hours: May 3, 2024, 7:22 PM EDT

Cardiol Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	130	55	32	81	-	-
Market Cap Growth	-	68.55%	-60.18%	-	-	-
Enterprise Value	95	29	-11	16	-11	-5
PE Ratio	-2.58	-2.58	-1.44	-3.29	-	-
PS Ratio	-	-	-	1323.13	-	-
PB Ratio	4.59	2.57	0.85	1.37	-	-
P/FCF Ratio	-2.88	-2.88	-1.63	-4.42	-	-
P/OCF Ratio	-2.89	-2.89	-1.63	-4.43	-	-
EV/Sales Ratio	-	-	-	259.37	-	-
EV/EBITDA Ratio	-1.36	-1.36	0.49	-0.65	0.68	0.50
EV/EBIT Ratio	-1.35	-1.35	0.48	-0.65	0.67	0.49
EV/FCF Ratio	-1.50	-1.50	0.55	-0.87	1.51	0.57
Debt / Equity Ratio	0.01	0.01	0.00	0.00	0.01	0.01
Debt / EBITDA Ratio	-0.01	-0.01	0.00	0.00	-0.01	-0.01
Debt / FCF Ratio	-0.01	-0.01	0.00	0.00	-0.02	-0.02
Quick Ratio	4.24	4.24	6.11	7.29	5.66	11.42
Current Ratio	4.36	4.36	6.27	7.54	5.94	20.81
Asset Turnover	0	0	0	0.00	0	-
Return on Equity (ROE)	-76.30%	-76.30%	-50.90%	-70.70%	-147.70%	-
Return on Assets (ROA)	-62.60%	-62.60%	-43.60%	-61.00%	-131.50%	-
Return on Capital (ROIC)	-104.80%	-104.80%	-79.07%	-50.64%	-154.10%	-95.05%
Earnings Yield	-21.71%	-38.71%	-69.65%	-30.36%	-	-
FCF Yield	-19.48%	-34.74%	-61.46%	-22.60%	-	-
Buyback Yield / Dilution	-3.13%	-3.13%	-44.61%	-44.77%	-15.63%	-
Total Shareholder Return	-3.13%	-3.13%	-44.61%	-44.77%	-15.63%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).